紫外线B光疗不增加特应性皮炎患者皮肤癌风险
该研究基于2001至2018年全国性人群队列,纳入6205例特应性皮炎患者,比较接受与未接受紫外线B光疗者的皮肤癌风险。结果显示,光疗组皮肤癌、非黑色素瘤皮肤癌和皮肤黑色素瘤的风险均未增加,且光疗次数与皮肤癌风险无关。
要点
- 紫外线B光疗未增加特应性皮炎患者皮肤癌风险(调整HR 0.91,95%CI 0.35-2.35)。
- 非黑色素瘤皮肤癌和皮肤黑色素瘤风险亦未增加,调整HR分别为0.80和0.80。
- 紫外线B光疗次数与皮肤癌风险无关(调整HR 0.99,95%CI 0.96-1.02)。
核心结论
- 紫外线B光疗及光疗次数均与特应性皮炎患者皮肤癌风险增加无关。
研究设计与样本
- 研究为2001至2018年全国性人群回顾性队列研究,纳入6205例特应性皮炎患者。
主要发现
- 接受紫外线B光疗的特应性皮炎患者皮肤癌风险未增加(调整HR 0.91,95%CI 0.35-2.35)。
- 非黑色素瘤皮肤癌风险未增加(调整HR 0.80,95%CI 0.29-2.26)。
- 皮肤黑色素瘤风险未增加(调整HR 0.80,95%CI 0.08-7.64)。
- 紫外线B光疗次数与皮肤癌风险无关(调整HR 0.99,95%CI 0.96-1.02)。
- 紫外线B光疗次数与非黑色素瘤皮肤癌风险无关(调整HR 0.99,95%CI 0.96-1.03)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 回顾性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: UV-B phototherapy is a common treatment modality for patients with atopic dermatitis (AD), but its long-term safety in terms of cutaneous carcinogenic risk has not been studied. OBJECTIVE: To investigate the risk of skin cancer among patients with AD receiving UV-B phototherapy. METHODS: We conducted a nationwide population-based cohort study from 2001 to 2018 to estimate the risk of UV-B phototherapy for skin cancer, nonmelanoma skin cancer, and cutaneous melanoma in patients with AD. RESULTS: Among 6205 patients with AD, the risks of skin cancer (adjusted hazard ratio [HR], 0.91; 95% CI, 0.35-2.35), nonmelanoma skin cancer (adjusted HR, 0.80; 95% CI, 0.29-2.26), and cutaneous melanoma (adjusted HR, 0.80; 95% CI, 0.08-7.64) did not increase among patients with AD treated with UV-B phototherapy, compared with those who did not receive UV-B phototherapy. Additionally, the number of UV-B phototherapy sessions was not associated with an increased risk of skin cancer (adjusted HR, 0.99; 95% CI, 0.96-1.02), nonmelanoma skin cancer (adjusted HR, 0.99; 95% CI, 0.96-1.03), or cutaneous melanoma (adjusted HR, 0.94; 95% CI, 0.77-1.15). LIMITATIONS: Retrospective study. CONCLUSION: Neither UV-B phototherapy nor the number of UV-B phototherapy sessions was associated with an increased risk of skin cancers among patients with AD.
引用
- Ko MJ, Tsai WC, Tsai PH, et al. Ultraviolet B phototherapy does not increase the risk of skin cancer among patients with atopic dermatitis: A population-based retrospective cohort study. J Am Acad Dermatol. 2023. PMID: 37236426. doi:10.1016/j.jaad.2023.05.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。